Retina implants are currently being developed by several interdisciplinary research consortia worldwide for blind humans with various retinal degenerative diseases. It is the aim of our retina implant project to develop a novel type of visual prosthesis to regain a moderate amount of vision such as perception of location and shape of large objects in the first stage and to approach reading quality in a subsequent stage. In our planned retina implant, a retina encoder (RE) outside the eye has to replace the information processing of the retina. A retina stimulator (RS), implanted adjacently to the retinal ganglion cell layer, has to contact a sufficient number of retinal ganglion cells/fibers for electrical elicitation of spikes. A wireless signal and energy transmission system has to provide the communication between the RE and RS. This paper outlines the retina implant project of our consortium of 14 expert groups and describes first results of the learning RE. The RE approximates the typical receptive field (RF) properties of primate retinal ganglion cells by means of individually tunable spatiotemporal RF filters. The RE as a cluster of RF filters maps visual patterns onto spike trains for a number of contacted ganglion cells. A concept is presented to train the individual RF filters in an unsupervised learning process, which employs neural networks in a dialog with the individual human subject. The desired aim of this dialog is an optimization of the visual perception by matching the various RF filter properties with those 'expected' by the central visual system for each contacted ganglion cell.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1159/000268026 | DOI Listing |
BMC Ophthalmol
January 2025
Department of Ophthalmology, Medical Faculty, University Hospital of Cologne, Kerpener Strasse 62, 50937, Cologne, Germany.
Background/ Aims: To analyze the longitudinal change in Bruch's membrane opening minimal rim width (BMO-MRW) and peripapillary retinal nerve fiber layer (pRNFL) thickness using optical coherence tomography (OCT) after implantation of a PRESERFLO® microshunt for surgical glaucoma management in adult glaucoma patients.
Methods: Retrospective data analysis of 59 eyes of 59 participants undergoing implantation of a PRESERFLO microshunt between 2019 and 2022 at a tertiary center for glaucoma management. Surgical management included primary temporary occlusion of the glaucoma shunt to prevent early hypotony.
GMS Ophthalmol Cases
December 2024
Department of Ophthalmology, Disha Eye Hospital, Siliguri, India.
Background: Pseudophakic cystoid macular edema (CME) following primary anterior-chamber intraocular lens (ACIOL) implantations is commonly seen. Intravitreal triamcinolone acetonide (IVTA) injections have shown significant improvement in visual acuity and retinal thickness in refractory pseudophakic CME. Pseudohypopyon following IVTA injection is a known entity.
View Article and Find Full Text PDFRetina
January 2025
Department of Ophthalmology, Harvard Medical School, Boston, MA, USA.
Purpose: To describe effects of sustained-release steroid delivery devices on intraocular pressure (IOP) in eyes with glaucoma drainage devices (GDD).
Methods: Retrospective case series of eyes with steroid implants (dexamethasone or fluocinolone acetonide) and prior GDD (Ahmed, Baerveldt) without uveitis. Outcomes included IOP, IOP rise, central foveal thickness (CFT), and IOP medications.
Int J Retina Vitreous
January 2025
Ophthal - Hospital Especializado, São Paulo, SP, Brazil.
Background: Clinically significant macular edema (CME) is the leading cause of visual loss after ophthalmologic surgery due to the release of inflammatory mediators promoted by the procedures. We aimed to evaluate the outcomes of intravitreal Ozurdex (700 µg dexamethasone) implants as a primary therapeutical option for post-surgical macular edema cases.
Methods: Patients with post-surgical macular edema diagnosed by optical coherence tomography (Cirrus SD-OCT) and treated with Ozudex were selected for the current study.
J Vitreoretin Dis
January 2025
Georgia Retina, Atlanta, GA, USA.
To compare the effects of intravitreal (IVT) 0.7 mg dexamethasone implants on the intraocular pressure (IOP) in Black patients and White patients with diabetic macular edema (DME). A retrospective cohort study was performed of Black patients and White patients with DME who received dexamethasone implants with 12 or more months of follow-up.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!